Sex hormones and innate immunity in tuberculosis

结核病中的性激素和先天免疫

基本信息

  • 批准号:
    10186699
  • 负责人:
  • 金额:
    $ 19.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-06-08 至 2023-05-31
  • 项目状态:
    已结题

项目摘要

Incidence and severity of many non-infectious and infectious diseases and vaccination efficacy differ between men and women. Although these effects could reflect sex (the biological differences between male and female) or gender (cultural norms associated with being male or female), a large body of evidence supports that these differences have a biological component. Tuberculosis (TB), a bacterial infectious disease that is one of the top ten causes of death worldwide, exhibits sex dimorphism. TB is more frequent and severe in men than women; human and murine studies demonstrate a biological component of the epidemiologically observed sex dimorphism. The present proposal stems from our surprising observation that human macrophages differentiated from monocytes ex vivo in absence of autologous serum exhibit sex bias in M. tuberculosis infection control. Sex bias was also observed in the accumulation of lipid droplets, a feature associated with decreased antimycobacterial macrophage activity that is regulated by mechanistic target of rapamycin complex 1 (mTORC1) signaling. The present proposal will determine whether sex hormones determine control of M. tuberculosis infection by inducing epigenetic reprogramming in monocytes/macrophages and involving mTORC1 signaling. The experimental plan stems from considerations derived from our preliminary results and the literature. First, the absence of autologus serum, and therefore endogenous sex hormones, in the above- mentioned experiments is consistent with the involvement of memory innate responses in the observed sex bias. Second, memory innate responses, which protect against TB, are epigenetically regulated. Third, mTORC1 signaling is regulated by sex hormones and also epigenetically. The clinical capacity and expertise at Rutgers University will provide access to populations that represent a diverse sex steroid hormone milieu: (a) cis-gender women taking hormonal contraceptives and women enrolled during and after pregnancy at the Rutgers NJMS OB/GYN clinic; and (b) transgender men and women at the Rutgers Center for Transgender Health. We have articulated this proposal in two aims. We will leverage variations of plasma levels of sex steroid hormones due to exogenous administration (Aim 1A) and pregnancy (Aim 1B) to determine relationships between hormonal levels, epigenetic profiles in immune cells, and control of M. tuberculosis infection. In Aim 2, we will determine whether the sex bias we observe in the macrophage control of M. tuberculosis infection is mTORC1-dependent. The results of the proposed work will guide interventional strategies against TB with respect to sex, pregnancy, and sex steroid hormonal therapy. Moreover, the fundamental and translational implications of the plan are generalizable to sex bias in many other diseases.
许多非传染性疾病和传染性疾病的发病率和严重程度以及疫苗接种效果在不同人群之间有所不同 男女。尽管这些影响可以反映性别(男性和女性之间的生物学差异) 或性别(与男性或女性相关的文化规范),大量证据支持这些 差异具有生物学成分。结核病(TB),一种细菌感染性疾病,是最常见的疾病之一 全球十大死亡原因,表现出性别二态性。男性结核病比女性更常见、更严重; 人类和小鼠研究证明了流行病学观察到的性别的生物学成分 二态性。目前的提议源于我们令人惊讶的观察,即人类巨噬细胞分化 在没有自体血清的情况下离体单核细胞在结核分枝杆菌感染控制中表现出性别偏见。性别 在脂滴的积累中也观察到了偏差,这是与减少相关的一个特征 受雷帕霉素复合物 1 机制靶标调节的抗分枝杆菌巨噬细胞活性 (mTORC1) 信号传导。目前的提案将确定性激素是否决定对支原体的控制。 通过诱导单核细胞/巨噬细胞表观遗传重编程并涉及 mTORC1 来控制结核感染 发信号。实验计划源于我们的初步结果和实际情况的考虑 文学。首先,在上述中不存在自体血清,因此不存在内源性激素—— 上述实验与观察到的性别偏见中记忆先天反应的参与是一致的。 其次,可预防结核病的记忆先天反应受到表观遗传调控。三、mTORC1 信号传导受到性激素和表观遗传的调节。罗格斯大学的临床能力和专业知识 大学将为代表不同性类固醇激素环境的人群提供机会:(a) 顺性别 服用激素避孕药的女性以及怀孕期间和怀孕后在罗格斯 NJMS 注册的女性 妇产科诊所; (b) 罗格斯跨性别健康中心的跨性别男性和女性。我们有 阐明了该提案的两个目标。我们将利用性类固醇激素血浆水平的变化 外源性给药(目标 1A)和妊娠(目标 1B)以确定激素之间的关系 水平、免疫细胞的表观遗传特征以及结核分枝杆菌感染的控制。在目标 2 中,我们将确定 我们在巨噬细胞控制结核分枝杆菌感染中观察到的性别偏见是否依赖于 mTORC1。 拟议工作的结果将指导针对性、怀孕、 和性类固醇激素治疗。此外,该计划的基本意义和转化意义是 普遍存在于许多其他疾病中的性别偏见。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Maria Laura Gennaro其他文献

Pragmatic Return to Effective Dental Infection Control through Triage and Testing (PREDICT): A feasibility study to improve dental office safety
通过分诊和测试务实地回归有效的牙科感染控制(PREDICT):提高牙科诊所安全性的可行性研究
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    J. Fredericks;Cecile A Feldman;V. Allareddy;Ellen Funkhouser;MaryAnn McBurnie;Cyril Meyerowitz;Pat Ragusa;Julie Chapman;Modupe Coker;D. Fine;Maria Laura Gennaro;Gayathri Subramanian
  • 通讯作者:
    Gayathri Subramanian
A site-specific recombination function in Staphylococcus aureus plasmids
金黄色葡萄球菌质粒中的位点特异性重组功能
  • DOI:
    10.1128/jb.169.6.2601-2610.1987
  • 发表时间:
    1987-06-01
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Maria Laura Gennaro;J. Kornblum;R. P. Novick
  • 通讯作者:
    R. P. Novick
Accuracy and utility of commercially available amplification and serologic tests for the diagnosis of minimal pulmonary tuberculosis.
市售扩增和血清学检测用于诊断轻微肺结核的准确性和实用性。
Molecular cloning, purification, and serological characterization of MPT63, a novel antigen secreted by Mycobacterium tuberculosis
结核分枝杆菌分泌的新型抗原 MPT63 的分子克隆、纯化和血清学表征
  • DOI:
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Claudia Manca;Konstantin P. Lyashchenko;H. Wiker;Donatella Usai;Donatella Usai;Roberto Colangeli;Maria Laura Gennaro
  • 通讯作者:
    Maria Laura Gennaro
Immunological Characterization of Antigens Encoded by the RD1 Region of the Mycobacterium tuberculosis Genome
结核分枝杆菌基因组 RD1 区域编码抗原的免疫学特征
  • DOI:
  • 发表时间:
    2001
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    P. Brusasca;Roberto Colangeli;Konstantin P. Lyashchenko;X. Zhao;M. Vogelstein;J. Spencer;David N. McMurray;Maria Laura Gennaro
  • 通讯作者:
    Maria Laura Gennaro

Maria Laura Gennaro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Maria Laura Gennaro', 18)}}的其他基金

COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)
COVID-19 网络网络扩展预测儿童严重疾病的临床和转化方法(CONNECT 预测患病儿童)
  • 批准号:
    10733696
  • 财政年份:
    2021
  • 资助金额:
    $ 19.61万
  • 项目类别:
COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)
COVID-19 网络网络扩展预测儿童严重疾病的临床和转化方法(CONNECT 预测患病儿童)
  • 批准号:
    10273971
  • 财政年份:
    2021
  • 资助金额:
    $ 19.61万
  • 项目类别:
COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)
COVID-19 网络网络扩展预测儿童严重疾病的临床和转化方法(CONNECT 预测患病儿童)
  • 批准号:
    10320995
  • 财政年份:
    2021
  • 资助金额:
    $ 19.61万
  • 项目类别:
COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)
COVID-19 网络网络扩展预测儿童严重疾病的临床和转化方法(CONNECT 预测患病儿童)
  • 批准号:
    10847827
  • 财政年份:
    2021
  • 资助金额:
    $ 19.61万
  • 项目类别:
Foam cells as drug targets in tuberculosis
泡沫细胞作为结核病的药物靶点
  • 批准号:
    10436308
  • 财政年份:
    2019
  • 资助金额:
    $ 19.61万
  • 项目类别:
Foam cells as drug targets in tuberculosis
泡沫细胞作为结核病的药物靶点
  • 批准号:
    10205167
  • 财政年份:
    2019
  • 资助金额:
    $ 19.61万
  • 项目类别:
Effects of donor plasma and recipient characteristics on convalescent plasma treatment outcome of COVID-19
供体血浆和受体特征对 COVID-19 恢复期血浆治疗结果的影响
  • 批准号:
    10225219
  • 财政年份:
    2019
  • 资助金额:
    $ 19.61万
  • 项目类别:
FISH-Flow platform for host-based tuberculosis diagnostics
用于基于宿主的结核病诊断的 FISH-Flow 平台
  • 批准号:
    8721843
  • 财政年份:
    2013
  • 资助金额:
    $ 19.61万
  • 项目类别:
FISH-Flow platform for host-based tuberculosis diagnostics
用于基于宿主的结核病诊断的 FISH-Flow 平台
  • 批准号:
    8895750
  • 财政年份:
    2013
  • 资助金额:
    $ 19.61万
  • 项目类别:
Biomarkers for tuberculosis: new questions, new tools
结核病生物标志物:新问题,新工具
  • 批准号:
    8529930
  • 财政年份:
    2013
  • 资助金额:
    $ 19.61万
  • 项目类别:

相似国自然基金

结核分枝杆菌基因Rv0621抗表面活性剂分子机理的深入研究
  • 批准号:
    81071316
  • 批准年份:
    2010
  • 资助金额:
    33.0 万元
  • 项目类别:
    面上项目

相似海外基金

Sex hormones and innate immunity in tuberculosis
结核病中的性激素和先天免疫
  • 批准号:
    10039645
  • 财政年份:
    2020
  • 资助金额:
    $ 19.61万
  • 项目类别:
METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSIS
代谢醛作为抗结核病的免疫效应物
  • 批准号:
    10633100
  • 财政年份:
    2020
  • 资助金额:
    $ 19.61万
  • 项目类别:
Development of a cell-based HTS for compounds with activity against tuberculosis
开发具有抗结核活性的基于细胞的 HTS 化合物
  • 批准号:
    7766196
  • 财政年份:
    2009
  • 资助金额:
    $ 19.61万
  • 项目类别:
Development of a cell-based HTS for compounds with activity against tuberculosis
开发具有抗结核活性的基于细胞的 HTS 化合物
  • 批准号:
    7897362
  • 财政年份:
    2009
  • 资助金额:
    $ 19.61万
  • 项目类别:
Development of a cell-based HTS for compounds with activity against tuberculosis
开发具有抗结核活性的基于细胞的 HTS 化合物
  • 批准号:
    8013855
  • 财政年份:
    2009
  • 资助金额:
    $ 19.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了